Optimising Renal Outcome in Myeloma Renal Failure

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to compare the effectiveness of bortezomib versus thalidomide in reducing free light chains in the blood of myeloma patients. In addition participants will receive bendamustine (chemotherapy) and dexamethasone (steroids), which increase the effectiveness of both bortezomib and thalidomide. The trial will also study whether an earlier reduction of free light chains increases the chances of the kidneys recovering.
Epistemonikos ID: 7c31a777bb49bb12dd81fde65df6eea69d04d5dc
First added on: May 12, 2024